{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:25:37Z","timestamp":1793431537268,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.parint.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T02:40:20Z","timestamp":1532140820000},"page":"715-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Congenital toxoplasmosis: An overview of the neurological and ocular manifestations"],"prefix":"10.1016","volume":"67","author":[{"given":"Khadija","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajihullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.parint.2018.07.004_bb0010","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4315\/0362-028X.JFP-11-417","article-title":"Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens","volume":"75","author":"Hoffmann","year":"2012","journal-title":"J. Food Prot."},{"issue":"9","key":"10.1016\/j.parint.2018.07.004_bb0015","first-page":"1179","article-title":"Isolation of viable Toxoplasma gondii cysts from brain samples for oral infection","volume":"16","author":"Puvanesuaran","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.parint.2018.07.004_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fmicb.2014.00385","article-title":"Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon","volume":"5","author":"Oz","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.parint.2018.07.004_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006040","article-title":"Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia","author":"Yolken","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0030","first-page":"29","article-title":"Toxoplasmosis during pregnancy","volume":"52","author":"Many","year":"2006","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.parint.2018.07.004_bb0035","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.4049\/jimmunol.181.12.8485","article-title":"Dendtritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection","volume":"18","author":"Bierly","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.parint.2018.07.004_bb0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1574-6976.2010.00215.x","article-title":"Protozoa traversal of the blood brain barrier to invade the central nervous system","volume":"34","author":"Elsheikha","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.parint.2018.07.004_bb0045","author":"H\u00f6kelek"},{"key":"10.1016\/j.parint.2018.07.004_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Food borne illness acquired in the United States major pathogens","volume":"17","author":"Scallan","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.parint.2018.07.004_bb0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3855\/jidc.3831","article-title":"Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran","volume":"8","author":"Sarkari","year":"2014","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.parint.2018.07.004_bb0060","author":"Centres for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0255-0857(21)03124-8","article-title":"Mother-to-child transmission and diagnosis of Toxoplasma gondii infection during pregnancy","volume":"21","author":"Singh","year":"2003","journal-title":"Indian J. Med. Microbiol."},{"issue":"7","key":"10.1016\/j.parint.2018.07.004_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2471\/BLT.12.111732","article-title":"The global burden of congenital toxoplasmosis: a systematic review","volume":"91","author":"Torgerson","year":"2013","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.parint.2018.07.004_bb0075","author":"Merck Manual"},{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/2249-4847.96772","article-title":"Neonatal hepatitis with toxoplasmosis","volume":"1","author":"Mohanty","year":"2012","journal-title":"J. Clin. Neonatol."},{"key":"10.1016\/j.parint.2018.07.004_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.12659\/MSM.883342","article-title":"Atovaquone ameliorates gastrointestinal toxoplasmosis complications in a pregnancy model","volume":"18","author":"Oz","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.parint.2018.07.004_bb0090","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1542\/peds.2013-2153","article-title":"Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence","volume":"133","author":"Wallon","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.parint.2018.07.004_bb0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.siny.2007.01.011","article-title":"Toxoplasmosis","volume":"12","author":"Petersen","year":"2007","journal-title":"Semin. Foetal. Neonatal. Med."},{"issue":"10","key":"10.1016\/j.parint.2018.07.004_bb0100","first-page":"2131","article-title":"Congenital toxoplasmosis","volume":"67","author":"Jones","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.parint.2018.07.004_bb0105","series-title":"Pediatric Toxoplasmosis Clinical Presentation","author":"Brook","year":"2015"},{"issue":"4","key":"10.1016\/j.parint.2018.07.004_bb0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jped.2014.04.001","article-title":"Utility and limitations of T. gondii-specific IgM serum antibodies in the diagnosis of congenital toxoplasmosis in Porto Alegre","volume":"90","author":"McLeod","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.parint.2018.07.004_bb0115","series-title":"Opthalmologic Manifestations of Toxoplasmosis","author":"Wu","year":"2015"},{"key":"10.1016\/j.parint.2018.07.004_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02306487","article-title":"Ocular toxoplasmosis; common and rare symptoms and signs","volume":"13","author":"De Jong","year":"1989","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.parint.2018.07.004_bb0125","author":"American Academy of Ophthalmology, Strabismus"},{"key":"10.1016\/j.parint.2018.07.004_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.06.002","article-title":"Long-term outcome of children with congenital toxoplasmosis","volume":"203","author":"Berr\u00e9bi","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.parint.2018.07.004_bb0135","series-title":"Infectious diseases of the fetus and newborn infant","first-page":"947","article-title":"Toxoplasmosis","volume":"6","author":"Remington","year":"2005"},{"issue":"3","key":"10.1016\/j.parint.2018.07.004_bb0140","first-page":"107","article-title":"Sero-epidemiology of toxoplasmosis amongst pregnant women in the greater Accra region of Ghana","volume":"43","author":"Ayi","year":"2009","journal-title":"Ghana Med. J."},{"key":"10.1016\/j.parint.2018.07.004_bb0145","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3860","article-title":"Diagnosis, treatment, and prevention of congenital toxoplamosis in the United States committee on infectious diseases","author":"Maldonado","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.parint.2018.07.004_bb0150","author":"Kivi"},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/INF.0b013e318134286d","article-title":"Risk factors for retinochoroiditis during the first 2\u202fyears of life in infants with treated congenital toxoplasmosis","volume":"27","author":"Keiffer","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"10","key":"10.1016\/j.parint.2018.07.004_bb0160","article-title":"Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study","volume":"7","author":"Cortina-Borja","year":"2010","journal-title":"EMSCOT"},{"issue":"12","key":"10.1016\/j.parint.2018.07.004_bb0165","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s10995-016-2084-z","article-title":"Indication of risk of mother-to-child Toxoplasma gondii transmission in the Greater Accra Region of Ghana","volume":"20","author":"Kwofie","year":"2016","journal-title":"Matern. Child Health J."},{"issue":"7","key":"10.1016\/j.parint.2018.07.004_bb0170","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1128\/JCM.40.7.2504-2508.2002","article-title":"VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women","volume":"40","author":"Montoya","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0175","first-page":"85","article-title":"Difficulty in dating primary infections by Toxoplasma gondii in pregnant women in Tunisia","volume":"84","author":"Emna","year":"2006","journal-title":"Tunis. Med."},{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/S0036-46652006000200007","article-title":"Toxoplasma IgM and IgG avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission","volume":"48","author":"Reis","year":"2008","journal-title":"Rev. Inst. Med. Trop. Sao Polo"},{"issue":"11","key":"10.1016\/j.parint.2018.07.004_bb0185","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1099\/jmm.0.47260-0","article-title":"Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis","volume":"56","author":"Iqbal","year":"2007","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.parint.2018.07.004_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S0950268803001948","article-title":"Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies","volume":"132","author":"Gras","year":"2004","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.parint.2018.07.004_bb0195","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/JCM.43.4.1570-1574.2005","article-title":"European multicenter study of LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index","volume":"43","author":"Petersen","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.parint.2018.07.004_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/infdis\/172.1.319","article-title":"Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma infection by detection of parasite in blood","volume":"172","author":"Guy","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.parint.2018.07.004_bb0205","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/JCM.42.4.1719-1722.2004","article-title":"Comparision of two widely used PCR primer systems for detection of Toxoplasma in amniotic fluid, blood and tissues","volume":"42","author":"Chabbert","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.parint.2018.07.004_bb0210","first-page":"536","article-title":"Diagnostic difficulties of Toxoplasma gondii infection in pregnant women. Is it possible to explain doubts by polymerase chain reaction?","volume":"76","author":"Slawska","year":"2005","journal-title":"Ginekol. Pol."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diagmicrobio.2008.09.009","article-title":"Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid","volume":"63","author":"Kasper","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.parint.2018.07.004_bb0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajo.2008.04.033","article-title":"Toxoplasmosis study group. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life","volume":"46","author":"Phan","year":"2008","journal-title":"Am J. Ophthalmol."},{"issue":"9556","key":"10.1016\/j.parint.2018.07.004_bb0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","article-title":"Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data, SYROCOT","volume":"369","author":"Thie'baut","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.parint.2018.07.004_bb0230","article-title":"Treatments for toxoplasmosis in pregnancy","volume":"2","author":"Peyron","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parint.2018.07.004_bb0235","series-title":"SOGC Clinical Practice Guideline","article-title":"Toxoplasmosis in pregnancy: prevention, screening, and treatment","author":"Paquet","year":"2013"},{"issue":"4","key":"10.1016\/j.parint.2018.07.004_bb0240","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/590149","article-title":"Management of Toxoplasma gondii infection during pregnancy","volume":"47","author":"Montoya","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0245","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.parint.2018.07.004_bb0250","author":"Diseases and Conditions Toxoplasmosis by Mayo Clinic Staff"},{"key":"10.1016\/j.parint.2018.07.004_bb0255","article-title":"Review of data related to side effects of drugs used in congenital toxoplasmosis","volume":"2","author":"Daveluy","year":"2005","journal-title":"Bordeaux Panel"},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0260","first-page":"104","article-title":"Long term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children","volume":"64","author":"Faucher","year":"2012","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.parint.2018.07.004_bb0265","series-title":"The National Collaborative Chicago-based Congenital Toxoplasmosis Study (NCCCT)","first-page":"1383","article-title":"Outcomes of treatment of congenital toxoplasmosis, 1981\u20132004","volume":"42(10)","author":"McLeod","year":"2006"},{"key":"10.1016\/j.parint.2018.07.004_bb0270","doi-asserted-by":"crossref","first-page":"e1215","DOI":"10.1542\/peds.2007-2169","article-title":"European multicentre study on congenital toxoplasmosis. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study","volume":"121","author":"Freeman","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1542\/peds.113.6.1567","article-title":"Long-term ocular prognosis in 327 children with congenital toxoplasmosis","volume":"113","author":"Wallon","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.parint.2018.07.004_bb0280","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2007.07.013","article-title":"Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis","volume":"144","author":"Tan","year":"2007","journal-title":"Am J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.parint.2018.07.004_bb0285","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/INF.0b013e3182343096","article-title":"Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants","volume":"30","author":"Olariu","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"11","key":"10.1016\/j.parint.2018.07.004_bb0290","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/cid\/cis264","article-title":"High burden of congenital toxoplasmosis in the United States: the strain hypothesis?","volume":"54","author":"Ajzenberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.parint.2018.07.004_bb0295","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/cid\/cis234","article-title":"Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy","volume":"54","author":"Hotop","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.parint.2018.07.004_bb0300","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1128\/CVI.00060-12","article-title":"Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis","volume":"19","author":"L'Ollivier","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"11","key":"10.1016\/j.parint.2018.07.004_bb0305","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/cid\/cis258","article-title":"Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981\u20132009)","volume":"54","author":"McLeod","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2018.07.004_bb0310","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40124-014-0055-7","article-title":"Management of congenital toxoplasmosis","volume":"2","author":"McLeod","year":"2014","journal-title":"Curr. Pediatr. Rep."},{"issue":"12","key":"10.1016\/j.parint.2018.07.004_bb0315","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/civ720","article-title":"Patterns of hydrocephalus caused by congenital Toxoplasma gondii infection associated with parasite genetics","volume":"61","author":"Hutson","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0320","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/ICU.0b013e328358bae5","article-title":"Ocular manifestations of systemic disease: toxoplasmosis","volume":"23","author":"Vasconcelos-Santos","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.parint.2018.07.004_bb0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13149-013-0287-8","article-title":"Toxoplasmosis mother-to-child screening: study of cases followed in the Pasteur Institute of Tunis (2007\u20132010)","volume":"106","author":"Ben Abdallah","year":"2013","journal-title":"Bull. Soc. Pathol. Exot."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0330","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jfo.2012.10.008","article-title":"Congenital toxoplasmosis: long-term ophthalmologic follow-up praised by patients","volume":"36","author":"Beraud","year":"2013","journal-title":"J. Fr. Ophtalmol."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000342625","article-title":"Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria","volume":"103","author":"Prusa","year":"2013","journal-title":"Neonatology"},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0340","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/MAO.0b013e31828297b6","article-title":"Otopathology in congenital toxoplasmosis","volume":"34","author":"Salviz","year":"2013","journal-title":"Otol. Neurotol."},{"issue":"9","key":"10.1016\/j.parint.2018.07.004_bb0345","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital Toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at 3\u202fyears","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2018.07.004_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-14-33","article-title":"Congenital toxoplasmosis and prenatal care state programs","volume":"14","author":"Avelino","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.parint.2018.07.004_bb0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2013.12.005","article-title":"Ocular toxoplasmosis past, present and new aspects of an old disease","volume":"39","author":"Maenz","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0360","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1756-0500-7-184","article-title":"Congenital toxoplasmosis presenting as central diabetes insipidus in an infant: a case report","volume":"7","author":"Mohamed","year":"2014","journal-title":"BMC Res. Notes"},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0365","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/INF.0000000000000256","article-title":"Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis","volume":"33","author":"Olariu","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"5","key":"10.1016\/j.parint.2018.07.004_bb0370","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.gyobfe.2014.01.020","article-title":"Toxoplasmic infections in pregnancy: About 94 cases diagnosed at the Pasteur Institute of Tunis","volume":"42","author":"Siala","year":"2014","journal-title":"Gynecol. Obstet. Fertil."},{"issue":"9","key":"10.1016\/j.parint.2018.07.004_bb0375","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/374647","article-title":"Serotyping of Toxoplasma gondii infections in humans using synthetic peptides","volume":"187","author":"Kong","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0380","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajo.2008.01.023","article-title":"Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis","volume":"145","author":"Holland","year":"2008","journal-title":"Am J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0385","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5301\/EJO.2011.6403","article-title":"Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis","volume":"2","author":"London","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.parint.2018.07.004_bb0390","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2147\/OPTH.S34294","article-title":"Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularisation","volume":"6","author":"Mansour","year":"2012","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000449169","article-title":"Recent developments in the diagnosis and treatment of ocular toxoplasmosis","volume":"57","author":"Ozgonul","year":"2017","journal-title":"Ophthalmic Res."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0400","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/09273948.2015.1057599","article-title":"Fulminant ocular toxoplasmosis: the hazards of corticosteroid monotherapy","volume":"24","author":"Oray","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.parint.2018.07.004_bb0405","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/09273948.2013.779724","article-title":"Therapy for ocular toxoplasmosis \u2013 the future","volume":"21","author":"Garweg","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0410","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bjo.77.6.371","article-title":"Ocular involvement in toxoplasmosis","volume":"77","author":"Rothova","year":"1993","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.parint.2018.07.004_bb0415","first-page":"920","article-title":"Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis","volume":"99","author":"Opremcak","year":"1992","journal-title":"AAO"},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira","year":"2002","journal-title":"Am J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.parint.2018.07.004_bb0425","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ajo.2013.12.022","article-title":"Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial","volume":"157","author":"Felix","year":"2014","journal-title":"Am J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"Am. J. Opthalmol."},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0435","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.parint.2018.07.004_bb0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"Am. J. Opthalmol."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576917305548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576917305548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:29:40Z","timestamp":1761301780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576917305548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1383576917305548"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2018.07.004","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital toxoplasmosis: An overview of the neurological and ocular manifestations","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}